Positive outcome of first-line therapy for a SMARCA4-deficient thoracic sarcomatoid tumor

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al. · Science · 2015 · 7.9K citations

Medicine, Immunology, Oncology +17

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Leora Witkowski, Jian Carrot‐Zhang, Steffen Albrecht et al. · Nature Genetics · 2014 · 500 citations

Medicine, Genetics, Oncology +14

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

François Le Loarer, Sarah Watson, Gaëlle Pierron et al. · Nature Genetics · 2015 · 364 citations

Medicine, Genetics, Oncology +15

Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome

Reinhard Schneppenheim, Michael C. Frühwald, Stefan Gesk et al. · The American Journal of Human Genetics · 2010 · 337 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

Natasha Rekhtman, Joseph Montecalvo, Jason C. Chang et al. · Journal of Thoracic Oncology · 2019 · 308 citations · Full text

Medicine, Molecular Genetics, Oncology +17